Analyst consensus rating
Jasper Therapeutics, Inc. - Class A Common Stock Analyst Consensus Rating
JSPR analyst consensus rating, coverage count and price target evidence.
Direct answer
Jasper Therapeutics, Inc. - Class A Common Stock's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.17.
Forecast evidence checked August 12, 2026.
Get free Jasper Therapeutics, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.82
- Average price target
- $9.17
- High price target
- $20.00
- Low price target
- $1.50
- Target upside
- +1,012.6%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026